期刊文献+

自拟益气强心汤治疗慢性心力衰竭(阳虚水停)的临床观察 被引量:3

Clinical observation on treating chronic heart failure(Yangxu Shuiting) with the Yiqi Qiangxin decoction
下载PDF
导出
摘要 目的:观察自拟益气强心汤对慢性心力衰竭的临床疗效。方法:100例慢性心力衰竭患者随机分为对照组和治疗组,对照组采用西医常规治疗,治疗组在与对照组相同的西医常规治疗基础上加服益气强心汤。4周后观察对比两组中医症候积分、心功能及LVEF变化情况。结果:治疗4周后,两组患者的心功能分级、中医症候及LVEF均有明显改善,且治疗组优于对照组。结论:在西药常规治疗基础上加用中药自拟益气强心汤,对阳虚水停型慢性心力衰竭疗效显著。 Objective:To observe clinical effects of the Yiqi Qiangxin decoction on chronic heart failure. Methods:100 patients were randomly divided into two groups, the control was given routine western medicine, while the treatment was given the Yiqi Qiangxin decoction more. Results:In 4 weeks treatment, NYHA classification, TCM symptoms and LVEF in two groups were obviously improved, especially in the treatment. Conclusion:Routine western medicine plus the Yiqi Qiangxin decoction shows good effects on chronic heart failure of Yangxu Shuiting syndrome.
作者 石云霄
机构地区 开封市中医院
出处 《中医临床研究》 2014年第31期50-51,共2页 Clinical Journal Of Chinese Medicine
关键词 慢性心力衰竭 阳虚水停 自拟益气强心汤 Chronic heart failure Yangxu Shuiting The Yiqi Qiangxin decoction
  • 相关文献

参考文献11

二级参考文献64

  • 1吕文伟,雷春利,陈羽,江岩.黄芪多糖对急梗犬心的保护作用及其机制分析[J].中草药,1994,25(11):586-589. 被引量:28
  • 2张晓丹,张茹,余自云,刘琳.补阳还五汤与黄芪对心力衰竭豚鼠强心作用的比较[J].中国心血管杂志,2005,10(6):421-423. 被引量:4
  • 3王方正,张澍,黄德嘉,华伟,孙宝贵,沈法荣,吴书林,王建安,方全,吴立群,王景峰,王冬梅,郭涛,陈新,中华医学会心电生理和起搏分会心脏再同步治疗专家工作组.心脏再同步治疗慢性心力衰竭的建议[J].中华心律失常学杂志,2006,10(2):90-102. 被引量:90
  • 4陈绍英 崔淑荣 庄生.应用组成分析评价肺心病急性发作期化瘀的治疗作用.中西医结合杂志,1998,(8):457-457.
  • 5Pober JS, Cotran RS. Cytokines and endothelial activation. Physiol Rev, 1990,70:427-451.
  • 6Colucci M, Paramo JA, Collen D. Generation in plasma of a fast acting inhibitor of plasminogen activator in response to endotoxin stimulation. J Clin Invest, 1985,75:818-824.
  • 7Ruan QR, Zhang WJ, Hufnagl P, et al. Anisodamine counteracts lipopolysaccharide-induced tissue factor and plasminogen activator inhibitor-1 expression in human endothelial cells: contribution of the NF-κB pathway. J Vasc Res, 2001, 38: 13-19.
  • 8Schneiderman J, Sawdey MS, Keeton MR, et al. Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries. Proc Natl Acad Sci U S A,1992,89:6998-7002.
  • 9Haverkate F. Levels of haemostatic fators, arteriosclarosis and cardiovascular disease. Vascul Pharmacol,2002,39:109-112.
  • 10Poredos P. Endothelial dysfunction in the pathogensis of atherosclerosis. Int Angiol, 2002,21:109-116.

共引文献5104

同被引文献30

引证文献3

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部